Chronic nephritic syndrome with other morphologic changes
ICD-10 N03.8 is a billable code used to indicate a diagnosis of chronic nephritic syndrome with other morphologic changes.
Chronic nephritic syndrome with other morphologic changes is characterized by persistent inflammation of the kidneys, leading to a range of clinical manifestations including proteinuria, hematuria, and hypertension. This condition often results from various underlying etiologies such as glomerulonephritis, which can be secondary to infections, autoimmune diseases, or systemic conditions. Patients typically present with symptoms such as edema, fatigue, and decreased urine output. Renal biopsy findings may reveal changes such as mesangial proliferation, glomerular sclerosis, or immune complex deposition, depending on the specific type of nephritis. Management in nephrology often includes controlling blood pressure, managing fluid overload, and addressing the underlying cause of the nephritis. Immunosuppressive therapy may be indicated in cases of autoimmune-related nephritis. Regular monitoring of renal function and proteinuria is essential to assess disease progression and treatment efficacy.
Detailed renal function tests, biopsy results, and treatment plans.
Patients presenting with unexplained proteinuria, hematuria, or renal insufficiency.
Ensure clear documentation of the type of nephritis and any associated systemic conditions.
Comprehensive reports on renal biopsy findings and histological analysis.
Evaluation of renal tissue samples for signs of glomerular disease.
Accurate correlation of biopsy findings with clinical symptoms for proper coding.
Used when a renal biopsy is performed to assess nephritic syndrome.
Biopsy report and clinical rationale for the procedure.
Nephrology specialists must ensure that the biopsy findings correlate with the diagnosis.
Key symptoms include hematuria, proteinuria, hypertension, and edema. Patients may also experience fatigue and decreased urine output.
Diagnosis typically involves a combination of clinical evaluation, laboratory tests showing proteinuria and hematuria, and renal biopsy to assess morphologic changes.
